Eton Pharmaceutcials
ETON
45 hedge funds and large institutions have $28.7M invested in Eton Pharmaceutcials in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 16 reducing their positions, and 6 closing their positions.
4,075% more call options, than puts
Call options by funds: $167K | Put options by funds: $4K
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
4.07% more ownership
Funds ownership: 29.87% → 33.94% (+4.1%)
2% more funds holding
Funds holding: 44 → 45 (+1)
0% less capital invested
Capital invested by funds: $28.8M → $28.7M (-$91.4K)
63% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.29M |
| 2 |
AC
Aristides Capital
Louisville,
Kentucky
|
+$700K |
| 3 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$447K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$385K |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$189K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$227K |
| 2 |
Goldman Sachs
New York
|
-$215K |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$180K |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$178K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$161K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Lazard Asset Management
New York
| – | -$2K | -576 | Closed |
|
ETON Hedge Fund Activity: Q2 2024 in Review
45 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q2 2024, worth a combined $28.7M — down 0.32% from $28.8M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ETON positions and 6 closed out — a net gain of 1 holder — while 6 added to existing stakes and 16 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $3.29M. The largest seller was Susquehanna International Group, cutting an estimated $227K.
- 45 institutional investors held Eton Pharmaceutcials (ETON) as of Q2 2024, up from 44 in Q1 2024.
- Funds reported $28.7M of Eton Pharmaceutcials stock for Q2 2024, down 0.32% quarter-over-quarter.
- 7 funds opened new Eton Pharmaceutcials positions in Q2 2024 and 6 closed out, a net change of +1 holder.
- The largest Eton Pharmaceutcials buyer in Q2 2024 was Nantahala Capital Management, an estimated $3.29M added.
- The largest Eton Pharmaceutcials seller in Q2 2024 was Susquehanna International Group, an estimated $227K sold.
Based on aggregated 13F filings for Q2 2024.